-
401por Laureano, Greice H. C., Torman, Vanessa B. L., Crispim, Sandra P., Dekkers, Arnold L. M., Camey, Suzi A.“…The methods Iowa State University (ISU), National Cancer Institute (NCI), Multiple Source Method (MSM) and Statistical Program to Assess Dietary Exposure (SPADE) were previously compared in another study, but some results were inconclusive due to the small number of replications used in the simulation. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
402por Maurea, Nicola, Spallarossa, Paolo, Cadeddu, Christian, Madonna, Rosalinda, Mele, Donato, Monte, Ines, Novo, Giuseppina, Pagliaro, Pasquale, Pepe, Alessia, Tocchetti, Carlo G., Zito, Concetta, Mercuro, Giuseppe“…The US National Cancer Institute estimates that cardiotoxicity (CTX) from target therapy refers mostly to four groups of drugs: epidermal growth factor receptor 2 inhibitors, angiogenic inhibitors, directed Abelson murine leukemia viral oncogene homolog inhibitors, and proteasome inhibitors. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
403Publicado 2016“…In response to this need, the National Cancer Institute has partnered with the National Institute of Biomedical Imaging and Bioengineering to create the National Institutes of Health Affordable Cancer Technologies (ACTs) program. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
404“…We recently published a paper entitled “Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma” in the Journal of the National Cancer Institute, providing a potential explanation for this limited benefit. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
405por Gulec, Seza“…Recent studies have identified a mutation or a genetic alteration in 95% of thyroid cancers. The National Cancer Institute initiated the Cancer Genome Atlas project in 2006 to catalogue genetic mutations associated with cancer, using genome sequencing and bioinformatics. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
406por Makumi, David“…David is currently the Chair of the Kenya Network of Cancer Organizations, thus he represents civil society on the Board of the National Cancer Institute of Kenya. At the international level, David sits on the International Advisory Panel of the ONS. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
407por Lancellotta, Valentina, Russo, Giuseppe, Lupattelli, Marco, Iacco, Martina, Perrucci, Elisabetta, Zucchetti, Claudio, Falcinelli, Lorenzo, Aristei, Cynthia“…Toxicity was evaluated on the National Cancer Institute’s common toxicity criteria (CTCAE 3.0). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
408por Hurwitz, Stephanie N., Rider, Mark A., Bundy, Joseph L., Liu, Xia, Singh, Rakesh K., Meckes, David G.“…Using sixty cell lines from the National Cancer Institute (NCI-60), here we provide the largest proteomic profile of EVs in a single study, identifying 6,071 proteins with 213 common to all isolates. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
409“…We obtained data from the Surveillance, Epidemiology, and End Results program of the National Cancer Institute merged with Medicare claims data. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
410por Tsubono, Yoshitaka, Okubo, Shunji, Hayashi, Masato, Kakizoe, Tadao, Tsugane, Shoichiro“…However, in response to a National Cancer Institute press report released on January 18, 1996, indicating that two beta‐carotene trials had shown no benefit and potential harm from the supplement, we discontinued the beta‐carotene and continued with the trial using only vitamin C. …”
Publicado 1997
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
411“…Axicabtagene ciloleucel (axi-cel) is an anti-CD19 chimeric antigen receptor T-cell therapy that was initially developed at the National Cancer Institute and has recently been commercially approved by the US Food and Drug Administration for relapsed or refractory aggressive non-Hodgkin’s lymphomas including diffuse large B-cell lymphoma and its variants. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
412por Shankar, Abhishek, Thakur, Rakesh, Meshram, Nandu, Keditsu, Keduovinuo, Srinivas, Priya“…Center for Global Health of National Cancer Institute, USA initiated summer curriculum is an excellent academic program to teach health care professionals working in cancer care in different parts of world. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
413por Steponavičienė, Laura, Gudavičienė, Daiva, Briedienė, Rūta, Petroška, Donatas, Garnelytė, Aušra“…From the database of the National Centre of Pathology (NCP), we obtained pathology reports of 19 patients with histologically confirmed EPC, who were treated at the National Cancer Institute (NCI) in Vilnius, Lithuania, between July 2009 and July 2015. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
414por Mendoza-Cervantes, Diana, Otero, Isabel, Zujewski, Jo Anne, Ferrandiz Salazar, Jorge, López Córdova, Gabriela, Muha, Cathy, Stevens, Lisa“…In these countries, there are disproportionately higher mortality to incidence ratios compared with other regions in Latin America. The US National Cancer Institute’s Center for Global Health, the Pan American Health Organization, and the Ministry of Health in Peru collaborated to design and execute an education and advocacy workshop in Lima, Peru. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
415por McCloud, Thomas G.“…The Developmental Therapeutics Program (DTP) of the U.S. National Cancer Institute (NCI), at its NCI-Frederick facility, has built perhaps the largest and most diverse natural products screening library in the world for drug discovery. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
416“…Frequency of shopping was assessed using self-report. The National Cancer Institute Fruit and Vegetable screener was used to calculate daily servings of fruits and vegetables. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
417“…MATERIAL/METHODS: A cohort of Ewing sarcoma patients aged over 40 years from 1973 to 2015 was identified from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
418por Popovici, Lacramioara, Amarandi, Roxana-Maria, Mangalagiu, Ionel I., Mangalagiu, Violeta, Danac, Ramona“…Fourteen of the new compounds were evaluated for their in vitro cytotoxic activity by National Cancer Institute (NCI) against 60 human tumour cell lines panel. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
419por Pogorzelska, Aneta, Sławiński, Jarosław, Brożewicz, Kamil, Ulenberg, Szymon, Bączek, Tomasz“…A series of new 3-amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine derivatives 5a–j have been synthesized and evaluated in vitro for their antiproliferative activity at the U.S. National Cancer Institute. The most active compound 5h showed significant cytotoxic effects against ovarian (OVCAR-3) and breast (MDA-MB-468) cancer (10% and 47% cancer cell death, respectively) as well as a good selectivity toward prostate (DU-145), colon (SW-620) and renal (TK-10) cancer cell lines. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
420por Ganenko, Denis, Dulskas, Audrius, Kuliešius, Žygimantas, Baltruškevičienė, Edita, Urbonas, Vincas, Stratilatovas, Eugenijus“…We analysed the association of treatment and its timing with survival among patients who were diagnosed and underwent surgery for stage II or III colon cancer from 2012 to 2013 at the National Cancer Institute, Lithuania. RESULTS. Of the 86 patients, 78% were still alive on December 31, 2013. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto